| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | Chief Executive Officer
1 company
Evans John M. is a CEO at Beam Therapeutics Inc.. Recent SEC Form 4 filings include 0 buys and 60 sells.
Estimated insider holdings value: $31.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2022 | BEAM Beam Therapeutics Inc. | CEO | Sell | 50,000 | $65.76 | $3,288,081.17 | -0.8% | -27.6% | -52.2% | |
| Apr 28, 2022 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 50,000 | $37.98 | $1,898,899.31 | -0.8% | +71.4% | -22.4% | |
| Mar 31, 2022 | BEAM Beam Therapeutics Inc. | CEO | Sell | 6,261 | $59.11 | $370,087.71 | -0.6% | -29.5% | -46.6% | |
| Oct 6, 2021 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 47,700 | $83.80 | $3,997,268.07 | -1.0% | -6.7% | -38.8% | |
| Aug 19, 2021 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 20,000 | $99.49 | $1,989,744.32 | -1.5% | -9.1% | -45.5% | |
| Jul 7, 2021 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 25,000 | $107.87 | $2,696,826.34 | -0.2% | -12.8% | -47.4% | |
| Apr 21, 2021 | BEAM Beam Therapeutics Inc. | CEO | Sale+OE | 25,000 | $70.49 | $1,762,215.61 | -0.5% | +27.8% | -43.3% | |
| Dec 30, 2020 | BEAM Beam Therapeutics Inc. | CEO | Sell | 22,300 | $84.94 | $1,894,124.84 | -0.3% | - | - |